Chargement en cours...
An observational, multicentre study of cabazitaxel in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel (CAPRISTANA)
OBJECTIVES: To obtain routine clinical practice data on cabazitaxel usage patterns for patients with metastatic castration‐resistant prostate cancer (mCRPC) and to describe physician‐assessed cabazitaxel effectiveness, health‐related quality of life (HRQoL) and safety. PATIENTS AND METHODS: CAPRISTA...
Enregistré dans:
| Publié dans: | BJU Int |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7379594/ https://ncbi.nlm.nih.gov/pubmed/30098093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.14509 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|